6505--Carbidopa Levodopa Immediate Release (IR) Tablets

Closed Pre-Solicitation Posted

Not the latest version. See the latest solicitation from .

Solicitation number
36E79726R0008
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs National Acquisition Center is conducting an unrestricted procurement for Carbidopa Levodopa Immediate Release (IR) Tablets to serve the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The VA intends to award a single contract to a responsible offeror capable of providing an uninterrupted supply of the medication in multiple formulations and package sizes. Key contract requirements include that offerors must provide an exact drug name as it appears on the label, possess a unique NDC number assigned to the offeror, and ensure their label is the only label affixed to the product. The solicitation (36E79726R0008) will be issued in commercial item format in accordance with FAR Part 12 on or about December 18, 2025, with a tentative proposal closing date of January 8, 2026, at 2:30 PM Central Time. Interested vendors should monitor SAM.gov continuously for any solicitation amendments, and questions may be directed to Raymond.Roldan@va.gov.

This procurement carries no set-aside designations and will be open to all responsible sources. The contract will span a one-year base period with four optional one-year renewal periods, with contract items distributed through VA and DoD Pharmaceutical Prime Vendor Programs. The specific procurement covers three Carbidopa Levodopa formulations: 10MG/100MG, 25MG/100MG, and 25MG/250MG immediate release tablets, each available in 100, 500, and 1,000 tablet bottle configurations. No estimated annual requirements or award values are disclosed in the pre-solicitation notice. The NAICS code 325412 (Pharmaceutical Preparation Manufacturing) applies to this procurement, with the PSC code 6505 (Drugs and Biologicals) reflecting the pharmaceutical nature of the goods.

Notice text

PRE-SOLICITATION NOTICE:Â The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79726R0008 for an unrestricted procurement for Carbidopa Levodopa Immediate Release (IR)Tablets, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC).

VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs.

Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product.

Solicitation # 36E79726R0008 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about December 18, 2025 with a tentative closing date of January 8, 2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Ray Roldan. Questions can be emailed to Raymond.Roldan@va.gov.

The estimated annual requirements are as follows:Â Â

Item

Description

Package Size (Tablets per Bottle)

Total Estimated Annual Usage (Bottles)

1

Carbidopa 10MG/Levodopa 100MG IR Tablets

100

5,871

2a

Carbidopa 10MG/Levodopa 100MG IR Tablets

500

4,016

OR

OR

OR

OR

2b

Carbidopa 10MG/Levodopa 100MG IR Tablets

1,000

2,008

3

Carbidopa 25MG/Levodopa 100MG IR Tablets

100

97,411

4a

Carbidopa 25MG/Levodopa 100MG IR Tablets

500

118,764

OR

OR

OR

OR

4b

Carbidopa 25MG/Levodopa 100MG IR Tablets

1,000

59,382

5

Carbidopa 25MG/Levodopa 250MG IR Tablets

100

10,141

6a

Carbidopa 25MG/Levodopa 250MG IR Tablets

500

7,614

OR

OR

OR

OR

6b

Carbidopa 25MG/Levodopa 250MG IR Tablets

1,000

3,807

Files

File Type Posted
36E79726R0008_1.docx DOCX document

Notice history

Notice Type Posted
6505--Carbidopa Levodopa Immediate Release (IR) Tablets Latest solicitation Solicitation
This notice Original Pre-Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
6505--Sodium Bicarbonate Injection Vial Restricted to Made in America NAICS 325412 National Acquisition Center No set-aside
6505--Imatinib Tablets NAICS 325412 National Acquisition Center No set-aside
Methylphenidate ER NAICS 325412 Medical Supply Chain No set-aside
6505--FY27 Low Energy General Radiopharmaceuticals 36C25027Q0052 See Section 11 of the Cleveland and Kent, Ohio, United States · NAICS 325412 Veterans Integrated Service Network 10 No set-aside
Lidocaine 5% patches-request for information Kansas 66048, United States · NAICS 325412 Veterans Integrated Service Network 15 No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity